Stocks
Zynerba Pharmaceuticals (ZYNE) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 1.50 | 2.04 | 1.12 | 1.86 | 1.45 | 0.93 | |||
| Changes by years, y/y, % | -24% | +36% | -45% | +65% | -22% | -5.8% | |||
Zynerba Pharmaceuticals. Debt/EBITDA
Zynerba Pharmaceuticals. Debt/EBITDA, changes, %
Zynerba Pharmaceuticals (ZYNE) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | LTM ? | |||
| Debt/EBITDA | 1.69 | 1.62 | 1.46 | 1.24 | 0.93 | 0.93 | ||
| Changes by years, y/y, % | -27% | -18% | -20% | -32% | -45% | |||
| Changes by quarters, q/q, % | -7% | -4% | -10% | -15% | -25% | |||
